rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157 Heals Duodenal Ulcers Differently Depending on Whether Salivary Glands Are Present

RPEP-007922003Bedekovic, Vlado; Mise, Stjepan; Anic, Tomislav; Staresinic, Mario; Gjurasin, Miroslav; Kopljar, Mario; Kalogjera, Livije; Drvis, Petar; Boban Blagaic, Alenka; Batelja, Lovorka; Seiwerth, Sven; Sikiric, Predrag
Animal StudyPreliminary evidence
The takeaway

BPC-157 healed cysteamine-induced duodenal ulcers regardless of salivary gland presence, while standard anti-ulcer drugs lost effectiveness after sialoadenectomy (salivary gland removal) — revealing BPC-157's unique saliva-independent healing.

Saliva-independent

Standard ulcer drugs NEEDED salivary glands to work, but BPC-157 didn't — healing through a fundamentally different, more robust mechanism

What the researchers found

BPC-157 maintained duodenal ulcer healing after sialoadenectomy while cimetidine and ranitidine lost effectiveness, demonstrating BPC-157's independence from salivary gland-derived protective factors — a unique pharmacological property.

Why it matters

Patients with Sjögren's syndrome and other conditions affecting salivary function may not respond to conventional ulcer drugs. BPC-157's saliva-independent healing could benefit these patients.

How the study worked

Animal study in rats with cysteamine-induced duodenal ulcers. Three conditions: normal rats, sialoadenectomized rats (no salivary glands), and gastrectomized rats (no stomach). BPC-157 and standard anti-ulcer drugs compared.

What this study cannot tell us

Rat model. Sialoadenectomy is more complete than clinical salivary dysfunction. The specific salivary factors involved were not identified.

How to read the evidence

Preliminary animal evidence with elegant three-condition design (normal, sialoadenectomized, gastrectomized) revealing a unique pharmacological property.

When this study was published

Published in 2003. BPC-157's independence from standard protective mechanisms continues to distinguish it from conventional gastroprotective drugs.

The bigger picture

The finding that conventional drugs depend on salivary factors while BPC-157 doesn't reveals fundamental differences in healing mechanisms — BPC-157 accesses repair pathways that are independent of the usual protective systems.

Questions still open

  • Which salivary factors do standard ulcer drugs depend on?
  • Could BPC-157 help patients with dry mouth-related GI problems?
  • Does BPC-157 replace the protective role of salivary factors?

Common questions

Why do salivary glands matter for gut healing?
Saliva contains protective factors that help standard ulcer drugs work. When salivary glands are removed or dysfunctional (as in Sjögren's syndrome), conventional drugs become less effective — but BPC-157 works regardless.
Is this relevant to dry mouth patients?
Potentially very relevant. People with chronic dry mouth (from Sjögren's, medications, or radiation therapy) may not respond well to standard GI drugs. BPC-157's saliva-independent healing could benefit these patients specifically.

Read the original research

Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.

European journal of pharmacology, 477(1), 73-80

View on PubMed ↗

Citation

Bedekovic, Vlado; Mise, Stjepan; Anic, Tomislav; Staresinic, Mario; Gjurasin, Miroslav; Kopljar, Mario; Kalogjera, Livije; Drvis, Petar; Boban Blagaic, Alenka; Batelja, Lovorka; Seiwerth, Sven; Sikiric, Predrag. (2003). Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.. European journal of pharmacology, 477(1), 73-80.